Literature DB >> 20944161

Long-term survival in uterine clear cell carcinoma and uterine papillary serous carcinoma.

Bengt Lindahl1, Jan Persson, Jonas Ranstam, Roger Willén.   

Abstract

Uterine clear cell carcinoma (UCC) and uterine papillary serous carcinoma (UPSC) are rare entities that differ in clinical behavior from endometrial adenocarcinoma. Compared with endometrioid adenocarcinoma, they more often metastasize early and more commonly in the upper abdomen including the omentum. Treatment programs of UCC and UPSC at different stages vary and range from no adjuvant therapy in stage Ia to a wide variety of chemotherapies and radiotherapies in more advanced stages. This study presents the outcome of 109 patients with UCC or UPSC treated according to essentially the same treatment program from May 1993 to December 2004. Most patients were treated with a simple hysterectomy with no further adjuvant treatment. In stage Ia, 2/46 patients died of their disease and amongst all the stages, 30/109 patients died of their disease. These survival outcomes are comparable to or better than those presented previously.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20944161

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  2 in total

1.  Clinicopathologic features and treatment in patients with early stage uterine clear cell carcinoma: A 16-year experience.

Authors:  Shannon D Armbruster; Rebecca Previs; Pamela T Soliman; Shannon N Westin; Bryan Fellman; Anuja Jhingran; Nicole D Fleming
Journal:  Gynecol Oncol       Date:  2019-06-18       Impact factor: 5.482

2.  Salvage intraperitoneal chemotherapy for relapsed type II endometrial cancer: A pilot case-control study.

Authors:  Yi-Chen Tsai; Yen-Hou Chang; Chi-Mu Chuang
Journal:  J Turk Ger Gynecol Assoc       Date:  2016-12-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.